Pre-Clinical Research into Stem Cells and its Application for Curing Intractable Diseases
―Our goal is to establish safe and efficacious gene or cellular therapy as a curative treatment for intractable blood/immune disorders by utilizing hematopoietic stem cells.

Research Projects

The Stem Cell Bank (i) conducts optimization and standardization of a protocol to establish disease-specific iPS cell lines for a broad range of medical and pharmacological studies, and (ii) supplies preserved iPS cells. Additionally the members of this section engage in basic research on the generation of blood cells, including hematopoietic stem cells, platelets, or red blood cells, in vitro from human ES cells / human iPS cells. The research program aims at the development of (i) safe and stable blood-product supplies for transfusion independently of blood donation and (ii) gene therapy using established hematopoietic stem cells derived from human iPS cells with an appropriate validation. In addition, recent program aims include the elucidation of molecular mechanisms, particularly those mediated through adhesion/integrin signaling, by which hematopoietic stem cells maintain quiescence.

Current News

2010/02/14

No information

Back to Top

About the Center for Stem Cell Biology and Regenerative Medicine, IMSUT
Center for Stem Cell Biology and Regenerative Medicine, IMSUT
Research Organizations

Division of Stem Cell Processing/Stem cell Bank, Center for Stem Cell Biology and Regenerative Medicine, IMSUT 4-6-1 Shirokanedai Minato-ku, Tokyo, 108-8639, Japan -81-3-5449-5397 +81-3-5449-5428 imsutscb(at)ims.u-tokyo.ac.jp

  • Center for Stem Cell Biology and Regenerative Medicine, IMSUT
  • Institute of Medical Science, the University of Tokyo
  • The University of Tokyo

Copyright 2017 © Center for Stem Cell Biology and Regenerative Medicinell.right reserved.